Glycosylation, as the most prominent posttranslational modification, is recognized as an important quality attribute of monoclonal antibodies affected by various bioprocess parameters and cellular physiology. A method of lectin-based bio-layer interferometry (LBLI) to relatively rank galactosylation and fucosylation levels was developed. For this purpose, Fc-glycosylated immunoglobulin G (IgG) was recombinantly produced with varying bioprocess conditions in 15 L bioreactor and accumulated IgG was harvested. The reliability, the robustness and the applicability of LBLI to different samples has been proven. Data obtained from LC-MS analysis served as reference and were compared to the LBLI results. The introduced method is based on non-fluidic bio-layer interferometry (BLI), which becomes recently a standard tool for determining biomolecular interactions in a label-free, real-time and high-throughput manner. For the intended purpose, biotinylated lectins were immobilized on disposable optical fiber streptavidin (SA) biosensor tips. Aleuria aurantia lectin (AAL) was used to detect the core fucose and Ricinus communis agglutinin 120 (RCA120) to determine galactosylation levels. In our case study it could be shown that fucosylation was not affected by variations in glucose feed concentration and cultivation temperature. However, the galactosylation could be correlated with the ratio of mean specific productivity (q P ) and ammonium (q NH4+ ) but was unrelated to the ratio of mean q P and the specific glucose consumption (q gluc ). This presented method strengthens the applicability of the BLI platform, which already enables measurement of several product related characteristics, such as product quantity as well as kinetic rates (k d ,k on ) and affinity constants (k D ) analysis.
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| INTRODUCTION
Monoclonal antibodies (mAbs) continue to dominate biopharmaceutical approvals and constitute about 40% of biotherapeutics that are available on the market and thus form a major class of molecules produced and developed by the biopharmaceutical industry. 1 Product quality and quantity are important measures in antibody discovery and in process development. These requirements are driven by numerous influential factors such as process performance and cell physiology. The complexity of such a multifactorial system makes it Jakob Wallner and Bernhard Sissolak contributed equally to this work.
difficult to identify the parameters with relevant influence on product quality. Thus, direct control of product quality in the individual bioprocess, a central goal of the quality by design approach, is severely limited. 2 Consequently, it is crucial to get a deeper understanding of the biological system, the process, the product and the interdependencies amongst each other.
In respect of product quality, the glycosylation is among others, a relevant characteristic, which can profoundly affect protein stability and the functions, which are relevant to their therapeutic application.
Recently, the correlation between the glycoform profiles and the safety and efficacy of a drug, in particular, has achieved significant attention of researchers worldwide. 3 The glycan structure is affected by the enzymatic machinery of the host cell, transit time in the Golgi bodies, environmental factors and the availability within the sugar nucleotide pool. [4] [5] [6] With respect to process conditions, several publications have shown that the osmolality level (in combination with pH), 7 Ricinus communis agglutinin 120 (RCA120) and Aleuria aurantia lectin (AAL) were used to determine the terminal galactose and core fucose content of the pre-purified IgG. 14 The resulting galactosylation and fucosylation levels were compared with results obtained by the well-established analysis technique using MS detection. 20 Since the harvest samples represent the accumulated product of the entire bioprocess, the glycosylation was further related to the overall process performance. To the best of our knowledge this study presents for the first time application of the BLI platform to determine the galactosylation and fucosylation levels of CHO culture samples.
| MATERIAL AND METHODS

| Bioprocess set up
As a model protein Fc-glycosylated anti-TNF-α IgG1 was used, produced The experimental setup used is displayed in Table 1 .
| Off-line analyses
The total cell concentration (TCC) was determined by counting the cell nuclei using a Z2 particle counter (Beckman Coulter). Therefore, an appropriate amount of cell suspension was centrifuged at 180g for 10 min. The cell pellet was subsequently resuspended in a 0.1 M citric acid monohydrate and 2% (vol/vol) Triton X-100 buffer to lyse the cells for a minimum of 1 hr before measurement. Sample dilution was performed using a 0.9% NaCl solution.
Culture viability was assessed using a haemocytometer and trypan blue exclusion. The viable cell concentration (VCC) was determined by multiplying viability with the TCC.
Glucose was determined via ion exclusion chromatography (HPX 87H, 300 × 7.8 mm, #1250140, BioRad) using an Agilent 1,200 series (Agilent) at 25 C. The mobile phase consisted of 5 mM sulphuric acid were added to each sample and the solution was vortexed, shortly before measurement.
Osmolality was measured by using a freezing point osmometer (Osmomat 030-D, Gonotec, Germany). Thawed samples of the cell broth supernatant were measured in duplicates.
The product titre was determined by BLI using Protein A tips (Octet System, QK, ForteBio). absorbance at 280 nm to detect eluting antibody. Due to tailing of the elution, only the main portion of the peak was collected, resulting in a loss of~5% in the tail.
| Reduction of disulphide bonds
Purified IgG was diluted with PBS to a concentration of 100 μg/mL (± 5 μg/mL), as determined by absorbance at 280 nm, using ε 1.43. 
| Monosaccharide analysis performed with mass spectrometry
The samples were digested in gel. The proteins were S-alkylated with Selected IgG samples of defined bioprocesses were purified using Protein A affinity chromatography to remove potential inferring host cell proteins. For this approach, in principle also other procedures (e.g., immunoprecipitation, etc.) could be applied as long as the glycosylation of IgGs is not affected. After the purification procedure, IgG was diluted to a concentration of 100 μg/mL determined by absorbance at 280 nm. In a first step lectin binding to non-reduced IgG was tested. As expected, binding of non-reduced IgG to the immobilized lectins could not be achieved (see Figure S1 ). These results are in excellent agreement with published data and provide additional evidence that reduction of IgG is a prerequisite to obtain freely accessible carbohydrate structures attached to the Fc part of the IgG. 18, 19, 25 Consequently, IgG was reduced with β-mercaptoethanol followed by carboxymethylation of cysteines with iodoacetamide to avoid reformation of the disulphide linkages. 26 For the BLI assay, the lectin and the IgG concentration was adjusted to gain an optimized test performance as described in the materials and methods section. Finally, SA biosensor tips were captured to saturation with biotinylated lectins (data not shown). An additional equilibration step with buffer was applied to remove the excess of biotinylated lectins and to obtain a constant loading baseline. The equilibration time was 60 s to achieve a sufficient baseline signal. Moreover, the lectin-coated SA biosensor tips were incubated with the purified, order to measure the baseline signal for calculation of the LOQ, which is defined as the lowest concentration at which the analyte can not only be reliably detected but at which some predefined goals for bias and imprecision are met. To obtain LOQ datasets for the evaluation of significant/reliable measurements, the average baseline noise of SA biosensor tips in PBS was determined and the LOQ assumed to be a signalto-noise ratio of 10:1. 27 The baseline noise of the initial 60 s was 0.004 nm (n = 8). Thus, the LOQ was calculated as 0.04 nm. From the dose-response linearity measurements, as explained above, it was found that the mean R t of the lowest used IgG concentrations (1.875 μg/mL) toward the pre-coated RCA120 lectin sensor was 0.068. Prior reduction
IgG was diluted to a concentration of 100 μg/mL. However, doseresponse linearity experiments and estimation of LOQ demonstrate that significant lower initial IgG concentration can be applied. For both, galactose and fucose, it could be demonstrated that the lectin-BLI (LBLI) is a promising tool when the accessibility of the protected sugar moieties can be achieved.
| Determination of fucosylation of IgG in different mammalian cell culture processes
In a next step the LBLI method was compared to a widely used standard approach for determining glycan structures. Therefore, the selected 13 harvest samples were purified and glycosylation levels were measured via LC-MS and the LBLI method as described above (data is shown in Table S1 ). In general, the fucosylated forms of the harvest product were constant within the experimental setup. With both methods a similar fucosylation level (Figure 3a) was determined. The level range was found to be 82.3 ± 1.2% with respect to the LC-MS analysis. The new established LBLI method obtained a mean value of R T 1.11 ± 0.09 nm. A regression analysis in order to compare both methods was not feasible due to the constant output.
| Determination of galactosylation of immunoglobulin G in different mammalian cell culture processes
Significant variations were observed for the galactosylation of the mAb. were equal compared to the LBLI results.
| Process parameters affecting glycosylation
The product is continuously secreted into the supernatant. The finally determined glycosylation pattern, represents the accumulated profile from the entire production process. Connecting the overall process performance with the glycosylation can already provide an appropriate picture about certain impacts. However, for a comprehensive understanding of the impact of process and cellular dynamics on glycosylation, straightforward techniques that enable the analysis of samples throughout the process, will be beneficial.
Since, fucosylation levels stayed constant in all samples of the test case we merely focused on the evaluation of the galactosylation.
According to recent studies 10, [28] [29] [30] glucose and ammonium can be environmental key factors in context of mAb galactosylation.
Since the IgG is accumulated during the process in the supernatant, the average production (NH4 + ) and consumption (glucose) rate for the entire process should, presupposed that there is an impact, may reflect the overall variance of the glycosylation pattern. The rates q n were calculated according to Equation (1) . However, in the experimental runs different product titres were achieved, which means that different amounts of protein were available and susceptible to posttranslational modification. Accordingly, the rates q NH4 + and q gluc were set into a relationship with the specific protein production rate q p , which was also calculated according to Equation (1) .
n represents the glucose, ammonium or mAb, respectively, X v the amount of viable cells and μ the growth rate to a given time point.
The variable n feed represents the amount of substrate feed into the system. Hence, for mAb and ammonium this term becomes zero.
The results obtained from different experimental setups indicate that the average specific glucose uptake rate does not correlate with the galactosylation content (Figure 4a ). This finding may be attributed to the fact that glucose concentrations were never limiting throughout the processes. Reduced glucose level can negatively influence the galactosylation index due to a reduced availability of uridindiphsophate (UDP) sugars and decrease the galactosylation index. 8, 9 This observation points to the fact that other additional factors might influence the galactosylation.
In this respect, the ratio of mean q p to q NH4+ was calculated In this study we assumed that the rates were constant for an entire process run. Due to this simplification certain dynamics and correlations might be undetectable. For instance, the availability of glucose, due to glucose depletion or a low glucose uptake rate, might have had an influence on the galactosylation level (Figure 4c ).
It also remains unclear if the ammonium production rate or the ammonium concentration in the supernatant was the real cause for the determined glycosylation pattern (Figure 4d) . A clear understanding of the dynamics can only be achieved if the whole process progression is taken into consideration. In principle the presented LBLI method is capable of high throughput analysis. In this respect, the protein purification step still remains a bottleneck for this analysis. Therefore, future research will focus on different high throughput (HT) protein purification procedures to reduce the work load and to be capable to identify such process dynamics.
| CONCLUSION
The glycosylation is a relevant key quality attribute for monoclonal antibodies. It can be affected by many different factors, such as the expression system, process conditions, or media composition and feed protocols and thereof vary from batch to batch. 3 In this study we showed that the developed LBLI method, verified with data resulted from LC-MS, is feasible to determine the Fc fucosylation and galactosylation of an anti-TNF alpha antibody. Samples containing mAbs with varying glycosylation profiles were used to show the method applicability. By both applied analytical techniques it could be shown that fucosylation remained constant within the experimental design, while galactose varied. Based on the monitored glucose and ammonium levels it could deduce that a low ratio of q p to q NH4+ resulted finally in a reduced galactosylation level in harvest samples.
To gain more insight into the very complex process dynamics individ- The presented technique will accelerate cell line, media and process development but also will be important as a process monitoring tool.
To transfer the proposed platform to industrial application, automatization of protein capture need to be established to overcome this bottle neck for future analysis. Currently, different HT purification systems are under examination with the aim to complete the proposed platform.
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